Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses

As the global COVID-19 pandemic continues and new SARS-CoV-2 variants of concern emerge, vaccines remain an important tool for preventing the pandemic. The inactivated or subunit vaccines themselves generally exhibit low immunogenicity, which needs adjuvants to improve the immune response. We previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Yidan, Zhan, Yikang, Zhang, Yongli, Deng, Jieyi, Chen, Achun, Liu, Bingfeng, Zhang, Yiwen, Pan, Ting, Zhang, Wangjian, Zhang, Hui, He, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780597/
https://www.ncbi.nlm.nih.gov/pubmed/36569949
http://dx.doi.org/10.3389/fimmu.2022.992062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780597/
https://www.ncbi.nlm.nih.gov/pubmed/36569949
http://dx.doi.org/10.3389/fimmu.2022.992062

Ejemplares similares